Chronic lymphocytic leukemia (CLL) is a type of blood cancer that begins in the bone marrow. CLL is the most common type of leukemia in adults. There are almost 16,000 people diagnosed with CLL each year.
Treatment for chronic lymphocytic leukemia is in the midst of a revolutionary transformation. Clinicians and cancer researchers have embarked on a new era in the management of CLL with the development and approval of potent and effective targeted therapies. These therapies are tailored to individuals based on the bio-markers or specific characteristics of their disease.
Learn more about our Leukemia Program